About Alievio
Alievio is a company based in Durham (United States) founded in 2010. Alievio has raised $17.93 million across 11 funding rounds from investors including NIH, Charlotte Angel Fund and Triangle Angel Partners. Alievio offers products and services including Slot Games Platform and Login Service. Alievio operates in a competitive market with competitors including Glaukos, Myra Vision, Ivantis, Sensimed and Transcend Medical, among others.
- Headquarter Durham, United States
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$17.93 M (USD)
in 11 rounds
-
Latest Funding Round
$5.7 M (USD), Series A
Apr 11, 2018
-
Investors
NIH
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alievio
Alievio offers a comprehensive portfolio of products and services, including Slot Games Platform and Login Service.
Platform for playing slot games with bonuses and secure access.
Secure login system for online slot game participation.
Funding Insights of Alievio
Alievio has successfully raised a total of $17.93M across 11 strategic funding rounds. The most recent funding activity was a Series A round of $5.7 million completed in April 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Alievio
Alievio has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, Charlotte Angel Fund and Triangle Angel Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Venture capital investment opportunities are provided for accredited investors.
|
Locked | Locked | Locked | |
|
Investment opportunities in ophthalmic innovations are managed by InFocus.
|
Locked | Locked | Locked |
Investor details for Alievio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Alievio
Investment portfolio details for Alievio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Alievio
Detailed financials for Alievio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Alievio Comparisons
Peer comparison for Alievio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Alievio
Alievio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Glaukos, Myra Vision, Ivantis, Sensimed and Transcend Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of implants to treat glaucoma
|
|
| Locked | Locked | Locked |
Nanotechnology-based devices for glaucoma treatment are developed.
|
|
| Locked | Locked | Locked |
Implantable device to relieve intraocular pressure in open angle glaucoma
|
|
| Locked | Locked | Locked |
A contact lens-based platform for glaucoma monitoring is offered.
|
|
| Locked | Locked | Locked |
Minimally invasive glaucoma stents are developed to enhance aqueous outflow.
|
|
| Locked | Locked | Locked |
Glaucoma is treated via the implantable MicroShunt device in ophthalmology.
|
Detailed competitors of Alievio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Alievio
Complete news archive for Alievio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alievio
Alievio was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Alievio is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Ray Krauss is the current CEO of Alievio.
Alievio is a funded company, having raised a total of $17.93M across 11 funding rounds to date.
Alevio has developed a device for treating glaucoma to target intraocular pressure (IOP). The company has developed a small noninvasive device used to remove the intraocular pressure by draining the aqueous humor and enables the physicians to maintain the IOP by adjusting the pressure. The company claims that the outlet tube is as soft as a contact lens.
Alievio's top competitors include Glaukos, Myra Vision and Avisi Technologies.
Alievio offers Slot Games Platform and Login Service.
Alievio has 8 investors. Key investors include NIH, Charlotte Angel Fund, Triangle Angel Partners, VCapital, and InFocus Capital Partners.